SBI Securities’s Bluejay Diagnostics BJDX Stock Holding History

SBI Securities’s Portfolio BJDX Stock Details BJDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$258	Buy	+302	New	+$312	﹤0.01%	3330
2025 Q2	–	Sell	-5	Closed	-$75	–	4150
2025 Q1	$75	Buy	+5	New	+$77	﹤0.01%	3536

Other funds holding BJDX

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

SBI Securities's BJDX Position: Q3 2026 in Review

SBI Securities opened a new position in Bluejay Diagnostics (BJDX) in Q3 2026: 302 shares worth $258. The stake represents ﹤0.01% of the portfolio and ranks #3330 among its holdings. This is a return to the name: SBI Securities previously reported a position in BJDX as recently as Q1 2025.

SBI Securities first reported a position in BJDX in Q1 2025 and has held it in 2 quarters since. 2 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.

SBI Securities held 302 shares of Bluejay Diagnostics worth $258 as of Q3 2026.
Bluejay Diagnostics was a new SBI Securities position in Q3 2026.
Bluejay Diagnostics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3330 holding.
SBI Securities first reported a position in Bluejay Diagnostics in Q1 2025 and has held it in 2 quarters since.
2 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.